iPSZürich Symposium 2023
Zurich, Switzerland
14.04.2023
poster „Human chamber-specific Engineered Heart Tissue (EHT) model for investigating small-conductance calcium-activated potassium channel (KCa2) inhibitor as a promising therapy for atrial fibrillation”
Nadel, A. , Mackiewicz, U., Rozwadowska, N., Kolanowski, T.J
4th Polish Congress of Genetics
CRACOW, POLAND
27-30.06.2022
poster „Evaluation of the presence and function of small conductance calcium- activated potassium (KCa2) channel in human heart model using Engineered Heart Tissue (EHTs)"
Nadel, A. , Kałużna, E., Zimna, A., Rozwadowska, N., Kolanowski, T. J.
EMBO|FEBS Lecture Course: Ion channels and transporters
ERICE, ITALY
5-11.05.2022
Data Blitz „Human chamber-specific Engineered Heart Tissue (EHT) model for pharmacological studies of small conductance calcium-activated potassium channels (KCa2) - AP14145 inhibition studies”
Nadel, A. , Kałużna, E., Zimna, A., Rozwadowska, N., Kolanowski, T. J.
XXV Symposium of the Experimental Cardiology Section of the Polish Cardiac Society
KAZIMIERZ DOLNY, POLAND
21-23.10.2021
poster „Evaluation of the presence and function of small conductance calcium- activated potassium (KCa2) channel in human heart model using Engineered Heart Tissue (EHTs)"
Nadel, A. , Kałużna, E., Zimna, A., Rozwadowska, N., Kolanowski, T. J.
EMBO Workshop: Cardiomyocyte Biology
virtual event
31.05.2021– 2.06.2021
poster „Evaluation of the presence and function of small conductance calcium- activated potassium (KCa2) channel in human heart model using Engineered Heart Tissue (EHTs)"
Nadel, A. , Kałużna, E., Rozwadowska, N., Kolanowski, T. J.
IF- 4.323 MNiSW- 140.
IF- 10.675 MNiSW- 140.
IF- 7.675 MNiSW-100.
IF-3.2, MNiSW-100.